A Model for Determining the Optimum Histology of Sentinel Lymph Nodes in Breast Cancer

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2004 Apr 29

PMID 15113852

Citations 11

Authors

G Cserni

Affiliations

Soon will be listed here.

Abstract

Aims: To create and use a geometrical model for sentinel lymph node (SLN) histopathology in breast cancer.

Methods: The model involves a spherical metastasis randomly situated in an SLN. Two extreme situations are taken as the starting points. In one of these, the metastasis is seen in its largest dimension, whereas in the other it is only just visible, approximating 0 mm in size. Intermediate positions are analysed, with different metastasis sizes and different distances between the levels assessed by histology.

Results: The findings suggest that sections taken 1 mm apart afford a reasonable means of identifying almost all metastases measuring > 2 mm (referred to as macrometastases here). For nearly all micrometastases to be identified correctly according to the current TNM definitions (that is, metastases > 0.2 mm), a step sectioning protocol with levels of 250 microm or 200 microm would be adequate.

Conclusions: SLNs are the most likely sites of nodal metastasis. Macrometastases are of recognised prognostic relevance so that all should be identified, preferably correctly as macrometastases; an assessment of levels 1 mm apart appears satisfactory and sufficient for this aim. SLNs also offer an ideal method for the study of the significance of micrometastases; for this, step sections separated by 200 or 250 microm are a good choice.

Citing Articles

Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer.

Cotarelo C, Zschock-Manus A, Schmidt M, Schad A, Brochhausen C, Kirkpatrick C Clin Exp Metastasis. 2020; 38(1):61-72.

PMID: 33249518 PMC: 7882580. DOI: 10.1007/s10585-020-10065-9.

Correlative Detection of Isolated Single and Multi-Cellular Calcifications in the Internal Elastic Lamina of Human Coronary Artery Samples.

Wen H, Morales Martinez A, Miao H, Larsen T, Nguyen C, Bennett E Sci Rep. 2018; 8(1):10978.

PMID: 30030502 PMC: 6054664. DOI: 10.1038/s41598-018-29379-6.

Association of One-Step Nucleic Acid Amplification Detected Micrometastases with Tumour Biology and Adjuvant Chemotherapy.

Goussous G, Jafferbhoy S, Smyth N, Hammond L, Narayanan S, Kirby R Int J Breast Cancer. 2017; 2017:4971096.

PMID: 28695012 PMC: 5485356. DOI: 10.1155/2017/4971096.

Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy.

Wang Y, Reder N, Kang S, Glaser A, Yang Q, Wall M Cancer Res. 2017; 77(16):4506-4516.

PMID: 28615226 PMC: 5559330. DOI: 10.1158/0008-5472.CAN-17-0709.

Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy.

Weaver D, Le U, Dupuis S, Weaver K, Harlow S, Ashikaga T Am J Surg Pathol. 2009; 33(11):1583-9.

PMID: 19730364 PMC: 3008509. DOI: 10.1097/PAS.0b013e3181b274e7.

References

Millis R, Springall R, Lee A, Ryder K, Rytina E, Fentiman I . Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer. 2002; 86(3):396-401. PMC: 2375207. DOI: 10.1038/sj.bjc.6600070. View

Czerniecki B, Scheff A, Callans L, Spitz F, Bedrosian I, Conant E . Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer. 1999; 85(5):1098-103. View

van Diest P . Histopathological workup of sentinel lymph nodes: how much is enough?. J Clin Pathol. 2000; 52(12):871-3. PMC: 501650. DOI: 10.1136/jcp.52.12.871. View

Teng S, Dupont E, McCann C, Wang J, Bolano M, Durand K . Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?. Am Surg. 2000; 66(6):574-8. View

Cserni G . The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg. 2001; 67(1):86-91. View

Torrenga H, Rahusen F, Meijer S, Borgstein P, van Diest P . Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol. 2001; 54(7):550-2. PMC: 1731471. DOI: 10.1136/jcp.54.7.550. View

Sabel M, Zhang P, Barnwell J, Winston J, Hurd T, Edge S . Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma. J Surg Oncol. 2001; 77(4):243-6. DOI: 10.1002/jso.1103. View

Stitzenberg K, Calvo B, Iacocca M, Neelon B, Sansbury L, Dressler L . Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol. 2002; 117(5):729-37. DOI: 10.1309/7606-f158-ugjw-yble. View

Schwartz G, Giuliano A, Veronesi U . Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002; 33(6):579-89. DOI: 10.1053/hupa.2002.124117. View

10.

Cserni G . Sentinel lymph node histopathology in breast cancer. Am J Surg Pathol. 2002; 26(10):1368; author reply 1368. DOI: 10.1097/00000478-200210000-00015. View

11.

Jakub J, Diaz N, Ebert M, Cantor A, Reintgen D, Dupont E . Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg. 2002; 184(4):302-6. DOI: 10.1016/s0002-9610(02)00958-3. View

12.

Cserni G . Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol. 2002; 55(12):926-31. PMC: 1769842. DOI: 10.1136/jcp.55.12.926. View

13.

Diaz L, Hunt K, Ames F, Meric F, Kuerer H, Babiera G . Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol. 2003; 27(3):385-9. DOI: 10.1097/00000478-200303000-00012. View

14.

Weaver D . Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant?. Am J Surg Pathol. 2003; 27(6):842-5. DOI: 10.1097/00000478-200306000-00018. View

15.

Cserni G . Effect of increasing the surface sampled by imprint cytology on the intraoperative assessment of axillary sentinel lymph nodes in breast cancer patients. Am Surg. 2003; 69(5):419-23. View

16.

Cserni G, Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Bussolati G . Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer. 2003; 39(12):1654-67. DOI: 10.1016/s0959-8049(03)00203-x. View

17.

Cserni G . Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol. 2004; 28(2):275. DOI: 10.1097/00000478-200402000-00020. View

18.

Cserni G, Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W . Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol. 2004; 57(7):695-701. PMC: 1770358. DOI: 10.1136/jcp.2003.013599. View

19.

Huvos A, HUTTER R, Berg J . Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1971; 173(1):44-6. PMC: 1397119. DOI: 10.1097/00000658-197101000-00006. View

20.

Giuliano A, Dale P, Turner R, Morton D, Evans S, Krasne D . Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995; 222(3):394-9; discussion 399-401. PMC: 1234825. DOI: 10.1097/00000658-199509000-00016. View